Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Perspective Therapeutics
CATX
AMEX
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$13.12
-1.98
-13.11%
After Hours: 4:00 PM EDT
15 minutes delayed
Get Report
Comment
Perspective Therapeutics (CATX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Perspective Therapeutics (AMEX:CATX) Stock
Perspective Therapeutics Stock (AMEX: CATX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, September 10, 2024
Cantor Fitzgerald Reiterates Overweight on Pe...
Benzinga Newsdesk
Monday, September 09, 2024
Cantor Fitzgerald Reiterates Overweight on Pe...
Benzinga Newsdesk
Friday, September 06, 2024
Cantor Fitzgerald Reiterates Overweight on Pe...
Benzinga Newsdesk
Thursday, September 05, 2024
Perspective Therapeutics Says FDA Granted Fas...
Benzinga Newsdesk
Tuesday, September 03, 2024
Cantor Fitzgerald Reiterates Overweight on Pe...
Benzinga Newsdesk
Friday, August 16, 2024
RBC Capital Maintains Outperform on Perspecti...
Benzinga Newsdesk
Tuesday, August 13, 2024
Oppenheimer Maintains Outperform on Perspecti...
Benzinga Newsdesk
Monday, August 12, 2024
Perspective Therapeutics shares are trading l...
Benzinga Newsdesk
UPDATE: Perspective Therapeutics Q2 EPS $(0.1...
Benzinga Newsdesk
Thursday, July 25, 2024
B of A Securities Initiates Coverage On Persp...
Benzinga Newsdesk
Tuesday, June 25, 2024
Cantor Fitzgerald Reiterates Overweight on Pe...
Benzinga Newsdesk
Thursday, June 20, 2024
Cantor Fitzgerald Reiterates Overweight on Pe...
Benzinga Newsdesk
Tuesday, June 18, 2024
Oppenheimer Reiterates Outperform on Perspect...
Benzinga Newsdesk
Oppenheimer Reiterates Outperform on Perspect...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Pe...
Benzinga Newsdesk
Friday, June 14, 2024
RBC Capital Reiterates Outperform on Perspect...
Benzinga Newsdesk
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Avi Kapoor
Tuesday, June 11, 2024
Perspective Therapeutics Announces 1-For-10 R...
Benzinga Newsdesk
Monday, June 10, 2024
Perspective Therapeutics Announces Six Update...
Benzinga Newsdesk
Tuesday, June 04, 2024
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor
Friday, May 24, 2024
Perspective Therapeutics Prices $80M Underwri...
Benzinga Newsdesk
Thursday, May 16, 2024
Jones Trading Maintains Buy on Perspective Th...
Benzinga Newsdesk
Wednesday, May 15, 2024
Perspective Therapeutics Q1 2024 GAAP EPS $(0...
Benzinga Newsdesk
Tuesday, May 14, 2024
RBC Capital Initiates Coverage On Perspective...
Benzinga Newsdesk
Thursday, May 09, 2024
Cantor Fitzgerald Initiates Coverage On Persp...
Benzinga Newsdesk
Tuesday, April 30, 2024
FDA Selects Perspective Therapeutics To Parti...
Benzinga Newsdesk
Tuesday, April 09, 2024
B. Riley Securities Maintains Buy on Perspect...
Benzinga Newsdesk
Monday, April 01, 2024
Oppenheimer Reiterates Outperform on Perspect...
Benzinga Newsdesk
Thursday, March 28, 2024
Stocks Pause As Traders Reassess Interest Rate Path, Gold Makes New Highs, Bitcoin Rebounds: What's Driving Markets Thursday?
Piero Cingari
Perspective Therapeutics FY2023 EPS $(0.14) D...
Benzinga Newsdesk
Tuesday, March 19, 2024
Oppenheimer Reiterates Outperform on Perspect...
Benzinga Newsdesk
Monday, March 18, 2024
Perspective Therapeutics Announces Collaborat...
Benzinga Newsdesk
Tuesday, March 05, 2024
Perspective Therapeutics Acquires CGMP-Compli...
Benzinga Newsdesk
Monday, March 04, 2024
Perspective Therapeutics shares are trading h...
Benzinga Newsdesk
Perspective Therapeutics Shares Resume Trade
Benzinga Newsdesk
Perspective Therapeutics Announces $87.4M Pr...
Benzinga Newsdesk
Perspective Therapeutics Shares Halted, News ...
Benzinga Newsdesk
Thursday, February 15, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Friday, February 09, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, February 07, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Friday, February 02, 2024
Expensify And 3 Other Stocks Under $3 Insiders Are Buying
Avi Kapoor
Thursday, February 01, 2024
Perspective Therapeutics Signs License Agreem...
Benzinga Newsdesk
Wednesday, January 31, 2024
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor
Monday, January 29, 2024
Perspective Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor
Friday, January 26, 2024
Perspective Therapeutics shares are trading h...
Benzinga Newsdesk
B. Riley Securities Initiates Coverage On Per...
Benzinga Newsdesk
Thursday, January 18, 2024
Why Perspective Therapeutics (CATX) Shares Are Falling
Henry Khederian
Perspective Therapeutics Announces Pricing of...
Benzinga Newsdesk
Wednesday, January 17, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Perspective Therapeutics Announces Proposed P...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
